TLDR: The DEA’s reported California medical cannabis rejection turns on patient documentation: the agency reportedly says California permits dispensing without a written certification. That puts two phrases in the April rescheduling rule in focus, “other document” and “state law deems sufficient.” California law lets a medicinal retailer sell on a county-issued card or a physician’s recommendation; the open question is whether those documents meet the federal conditions. The broader reporting also describes objections to adult-use activity, and I doubt the DEA will accept medical and adult-use operations at the same location.
Marijuana Moment reports that the DEA is rejecting medical cannabis registration applicants in California and other states. In California, the reported objection to patient documentation puts two phrases in the federal rule in focus: “other document” and “state law deems sufficient.”
According to the report, an order to show cause sent to a California business states:
What the federal rule says about patient documentation
The April rescheduling rule provides a specific framework for evaluating that concern. Under 21 C.F.R. § 1301.13(k)(5), the relevant “certification or other document” must be one that “state law deems sufficient for a user to obtain marijuana or products containing marijuana for medical purposes.” Qualifying documentation “shall be sufficient” to permit dispensing, subject to specified conditions. The provision applies notwithstanding Part 1306 or other provisions of the DEA’s rules. 21 C.F.R. § 1301.13(k)(5) · AG Order No. 6754-2026, 91 Fed. Reg. 22714, 22722 (Apr. 28, 2026)
That language appears to incorporate a measure of deference to state law. The purpose for which state law accepts the document is part of the analysis: the provision concerns obtaining medical cannabis and permitting dispensing.
The conditions also matter. The document must be dated and signed on the day it is issued, include the patient’s full name and address, and contain the signing practitioner’s name, address, and state license number. The practitioner must be authorized under state law to issue it. 21 C.F.R. § 1301.13(k)(5)
What California requires for physician documentation
California already requires physician documentation for its medical cannabis identification card program. Health and Safety Code § 11362.715(a)(2) requires documentation in the patient’s medical records stating that the patient has a serious medical condition and that medicinal cannabis is appropriate. Subsection (a)(3) also requires identifying information about the physician. The DEA cites this provision in arguing that California does not require a written certification satisfying the federal dispensing rule. Health & Safety Code § 11362.715(a)(2)-(3) · Marijuana Moment, Nov. 11, 2026
That differs from the self-certification pathway for adults 21 and older in D.C., which allows registration without a healthcare provider’s recommendation. In my view, a pure self-certification objection is more cut and dry than California’s dispute over physician documentation. California’s documents still need to be evaluated against the federal requirements. D.C. ABCA, Medical Cannabis Patients · 21 C.F.R. § 1301.13(k)(5)
That section addresses documentation submitted to obtain a state identification card. The federal provision addresses documentation sufficient under state law to obtain medical cannabis. The relationship between those requirements needs to be established; satisfying the card application requirement does not, by itself, establish federal dispensing sufficiency. 21 C.F.R. § 1301.13(k)(5) · Health & Safety Code § 11362.715(a)(2)-(3)
California’s retail rules also matter. Under 4 C.C.R. § 15404(b), medicinal retail sales require a valid physician’s recommendation and confirmation of the customer’s age, identity, and recommendation. Those retail requirements belong in the analysis alongside the card application rules. 4 C.C.R. § 15404(b) (DCC regulations text)
The statute also connects the medical card to retail purchasing. Business and Professions Code § 26140(c)(3) permits an M-licensee to sell to an eligible person age 18 or older who has valid government-issued identification and either a county-issued medical cannabis identification card or a physician’s recommendation. The remaining question is whether the card, the underlying physician documentation, or documentation used in that process satisfies § 1301.13(k)(5), including its practitioner-signature and identifying-information requirements. State purchasing eligibility does not automatically establish federal documentation compliance. Business & Professions Code § 26140(c)(3) · 21 C.F.R. § 1301.13(k)(5)
California’s optional CDPH 9044 form provides one way to document the physician’s determination for the card program. Its optional status does not resolve how a particular document functions under the state’s retail rules or the federal dispensing standard. Health & Safety Code § 11362.715(a)(2)-(3) · CDPH 9044
Where the scope of the federal language matters
I suspect the bounds of “other document” and “state law deems sufficient” are about to be tested, including the connection between documentation used to obtain a medical identification card and documentation sufficient to obtain cannabis at a dispensary.
A physician document may serve both purposes, but that connection needs evaluation. The assessment should identify the relevant document, its role under state law, and whether it meets the federal signature, date, and identifying-information requirements. The complete order and the applicant’s actual practices matter to that assessment.
The objections to adult-use cannabis activity
The broader reporting also identifies objections to adult-use cannabis activity. Marijuana Moment reports that DEA orders across several states generally cite businesses’ authority to sell nonmedical cannabis as conflicting with the Controlled Substances Act’s closed system and international treaty obligations. The quoted California excerpts address patient documentation; the broader reporting provides additional context for California operators. Marijuana Moment, Nov. 11, 2026
The Department of Justice’s October 30 announcement states that the federal framework covers qualifying medical cannabis activities and does not authorize recreational activity. It also states that applicants must satisfy federal requirements and treaty obligations, and that state licensure alone does not secure federal registration. That makes the relationship between medical and adult-use operations another issue to evaluate. DOJ announcement, Oct. 30, 2026 (updated Nov. 3, 2026)
Separate medical licenses and entities in California
California has created a process allowing qualifying retailers to separate their adult-use and medicinal licenses. DCC’s adopted regulations permit separate entities at the same premises under specified conditions, including shared individual owners and a designated responsible party, physical separation of cannabis goods, and separate inventory and business records. DCC-2026-03-E, final text, § 15000.2(b)
Those options provide flexibility under California law. DCC’s rulemaking materials describe the changes as a response to uncertainty about federal requirements. They do not establish that the DEA will accept a particular arrangement. DCC-2026-04-R, Initial Statement of Reasons
I have my doubts that the DEA will allow medical and adult-use activity to operate at the same location. A separate medical license or entity may be relevant to a business’s registration strategy, but it does not change what happens at the premises. Given the DEA’s reported objections to nonmedical activity, I expect continued adult-use operations at the same premises to receive significant scrutiny.
Any such arrangement needs to be assessed in light of the actual operations, including the adult-use activity at the same premises and the relationship between the entities. Patient documentation also requires its own review.
Could California align its certification requirements?
California could evaluate legislation expressly aligning patient-certification requirements with the federal documentation standard. A proposal could require a document that the practitioner signs and dates on the day it is issued, containing the patient information and practitioner information specified in the federal rule. It should address documentation sufficient for medicinal retail dispensing as well as documentation used in the identification card process. Revising an optional form alone may leave the underlying legal requirements unchanged. Whether reform is necessary, and whether a particular proposal would satisfy the DEA, would require further evaluation. 21 C.F.R. § 1301.13(k)(5) · Health & Safety Code § 11362.715 · CDPH 9044 · 4 C.C.R. § 15404(b)
Certification reform could help address the documentation issue. It would not, by itself, change adult-use activity at shared premises or resolve whether the DEA will accept a co-located medical and adult-use arrangement. Even if a revised certification process addressed the DEA’s documentation concerns, the agency’s broader objections to nonmedical activity would require separate analysis. California operators should evaluate both issues before treating certification changes as a complete route to registration.
What to assess after the California medical cannabis rejection
For California applicants, a useful assessment should connect each stated DEA concern to the relevant law and the operational evidence. That includes the patient documents actually accepted, employee verification procedures, license and entity arrangements, use of the premises, and movement of inventory.
Frequently asked questions
Why is the DEA reportedly rejecting California medical cannabis applicants?
According to Marijuana Moment, an order to show cause sent to a California business says California permits dispensing without a written certification. The broader reporting also describes objections to adult-use activity. The complete order was not reviewed for this article.
Will separating adult-use and medicinal licenses resolve the DEA’s objections?
Not by itself. California permits that separation, but that does not establish that the DEA will accept a particular arrangement, and patient documentation requires its own review.
Keep reading
Attorney advertising. General information only, not legal advice. No attorney-client relationship is created.
